AtriCure Inc (NAS:ATRC)
$ 23.76 2.565 (12.1%) Market Cap: 1.15 Bil Enterprise Value: 1.12 Bil PE Ratio: 0 PB Ratio: 2.52 GF Score: 66/100

Q4 2019 AtriCure Inc Earnings Call Transcript

Feb 18, 2020 / 09:30PM GMT
Release Date Price: $43.16 (-1.55%)
Operator

Good afternoon. And welcome to AtriCure Q4 and Full Year 2019 Earnings Conference Call. My name is Dilem, and I'll be your coordinator for the call today. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Lynn Lewis from Gilmartin Group for a few introductory comments.

Lynn Pieper Lewis
Gilmartin Group LLC - Founder & CEO

Thank you. By now you should have received a copy of the earnings press release. If you have not received a copy, please call (513) 755-4136 to have one e-mailed to you.

Before we begin today, let me remind you that the company's remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time to time in AtriCure's SEC filings.

AtriCure's results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot